BD is building on its goal of providing patients with a “one-stick hospital stay” with a new FDA clearance for painless blood collection hardware that works through already placed IV lines. The ...

Becton, Dickinson and Company BDX, popularly known as BD, recently received the FDA’s 510(k) clearance for the new BD Kiestra Methicillin-resistant Staphylococcus aureus (MRSA) imaging application.

Becton, Dickinson and Company BDX, also popularly known as BD, recently introduced its new fully-automated, high-throughput infectious disease molecular diagnostics platform in the United States. With ...